BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: LaMoia TE, Shulman GI. Cellular and Molecular Mechanisms of Metformin Action. Endocr Rev 2021;42:77-96. [PMID: 32897388 DOI: 10.1210/endrev/bnaa023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Rittig N, Aagaard NK, Sundelin E, Villadsen GE, Sandahl TD, Holst JJ, Hartmann B, Brøsen K, Grønbaek H, Jessen N. Metformin Stimulates Intestinal Glycolysis and Lactate Release: A single-Dose Study of Metformin in Patients With Intrahepatic Portosystemic Stent. Clin Pharmacol Ther 2021. [PMID: 34331316 DOI: 10.1002/cpt.2382] [Reference Citation Analysis]
2 Benham JL, Donovan LE, Yamamoto JM. Metformin in Pregnancy for Women with Type 2 Diabetes: a Review. Curr Diab Rep 2021;21:36. [PMID: 34495393 DOI: 10.1007/s11892-021-01409-0] [Reference Citation Analysis]
3 Mastrototaro L, Roden M. Insulin resistance and insulin sensitizing agents. Metabolism 2021;125:154892. [PMID: 34563556 DOI: 10.1016/j.metabol.2021.154892] [Reference Citation Analysis]
4 Rendell MS. Current and emerging gluconeogenesis inhibitors for the treatment of Type 2 diabetes. Expert Opin Pharmacother 2021;:1-13. [PMID: 34348528 DOI: 10.1080/14656566.2021.1958779] [Reference Citation Analysis]
5 Kahl S, Pützer J, Roden M. Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis. Semin Liver Dis 2021. [PMID: 34289506 DOI: 10.1055/s-0041-1732354] [Reference Citation Analysis]
6 Acar MB, Ayaz-Güner Ş, Gunaydin Z, Karakukcu M, Peluso G, Di Bernardo G, Özcan S, Galderisi U. Proteomic and Biological Analysis of the Effects of Metformin Senomorphics on the Mesenchymal Stromal Cells. Front Bioeng Biotechnol 2021;9:730813. [PMID: 34676202 DOI: 10.3389/fbioe.2021.730813] [Reference Citation Analysis]
7 Massimino E, Izzo A, Riccardi G, Della Pepa G. The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms. Cells 2021;10:1958. [PMID: 34440727 DOI: 10.3390/cells10081958] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hammad AM, Ibrahim YA, Khdair SI, Hall FS, Alfaraj M, Jarrar Y, Abed AF. Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-α. Behav Brain Res 2021;414:113475. [PMID: 34280460 DOI: 10.1016/j.bbr.2021.113475] [Reference Citation Analysis]
9 Kathuria D, Raul AD, Wanjari P, Bharatam PV. Biguanides: Species with versatile therapeutic applications. Eur J Med Chem 2021;219:113378. [PMID: 33857729 DOI: 10.1016/j.ejmech.2021.113378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Després JP, Carpentier AC, Tchernof A, Neeland IJ, Poirier P. Management of Obesity in Cardiovascular Practice: JACC Focus Seminar. J Am Coll Cardiol 2021;78:513-31. [PMID: 34325840 DOI: 10.1016/j.jacc.2021.05.035] [Reference Citation Analysis]
11 Eibl G, Rozengurt E. Metformin: review of epidemiology and mechanisms of action in pancreatic cancer. Cancer Metastasis Rev 2021. [PMID: 34142285 DOI: 10.1007/s10555-021-09977-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Tarazi MS, Touhamy S 2nd, Tchang BG, Shukla AP. Combined medical strategies for the management of type 2 diabetes mellitus and obesity in adults. Expert Opin Pharmacother 2021;:1-22. [PMID: 34165376 DOI: 10.1080/14656566.2021.1942841] [Reference Citation Analysis]
13 Kim HW. Metabolomic Approaches to Investigate the Effect of Metformin: An Overview. Int J Mol Sci 2021;22:10275. [PMID: 34638615 DOI: 10.3390/ijms221910275] [Reference Citation Analysis]
14 Grytsai O, Myrgorodska I, Rocchi S, Ronco C, Benhida R. Biguanides drugs: Past success stories and promising future for drug discovery. Eur J Med Chem 2021;224:113726. [PMID: 34364161 DOI: 10.1016/j.ejmech.2021.113726] [Reference Citation Analysis]
15 Lee MTW, Mahy W, Rackham MD. The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health. RSC Med Chem 2021;12:1281-311. [PMID: 34458736 DOI: 10.1039/d1md00113b] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Stojnić B, Serrano A, Sušak L, Palou A, Bonet ML, Ribot J. Protective Effects of Individual and Combined Low Dose Beta-Carotene and Metformin Treatments against High-Fat Diet-Induced Responses in Mice. Nutrients 2021;13:3607. [PMID: 34684608 DOI: 10.3390/nu13103607] [Reference Citation Analysis]
17 Ojha U, Reyes L, Eyenga F, Oumbe D, Watkowska J, Saint-Jacques H. Diabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors. Am J Cardiovasc Drugs 2021. [PMID: 34189716 DOI: 10.1007/s40256-021-00486-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sanz P, Serratosa JM, Sánchez MP. Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease. Int J Mol Sci 2021;22:5351. [PMID: 34069559 DOI: 10.3390/ijms22105351] [Reference Citation Analysis]
19 Markowicz-Piasecka M, Huttunen J, Zajda A, Sikora J, Huttunen KM. Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells. Chem Biol Interact 2021;352:109795. [PMID: 34953865 DOI: 10.1016/j.cbi.2021.109795] [Reference Citation Analysis]
20 Zhu Y, Fang Y, Medina D, Bartke A, Yuan R. Metformin treatment of juvenile mice alters aging-related developmental and metabolic phenotypes. Mech Ageing Dev 2021;201:111597. [PMID: 34780856 DOI: 10.1016/j.mad.2021.111597] [Reference Citation Analysis]
21 Yang J, Fang HJ, Cao Q, Mao ZW. The design of cyclometalated iridium(iii)-metformin complexes for hypoxic cancer treatment. Chem Commun (Camb) 2021;57:1093-6. [PMID: 33434260 DOI: 10.1039/d0cc07104h] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Shaheer A, Kumar A, Menon P, Jallo M, Basha S. Effect of Add-On Therapy of Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors on Adipokines in Type 2 Diabetes Mellitus. J Clin Med Res 2021;13:355-62. [PMID: 34267843 DOI: 10.14740/jocmr4510] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Roy A, Sahoo J. Long-term effects of metformin use in gestational diabetes mellitus on offspring health. World J Diabetes 2021; 12(11): 1812-1817 [PMID: 34888009 DOI: 10.4239/wjd.v12.i11.1812] [Reference Citation Analysis]
24 Chen L, Lv L, Zhang L, Gao Z, Liu Y, Wang S, Zhou N, Xia Y, Cui J, Jiang X, Zhang X, Li Y, Shi B. Metformin ameliorates bladder dysfunction in a rat model of partial bladder outlet obstruction. Am J Physiol Renal Physiol 2021;320:F838-58. [PMID: 33645317 DOI: 10.1152/ajprenal.00625.2020] [Reference Citation Analysis]
25 Hansel C, Barr S, Schemann AV, Lauber K, Hess J, Unger K, Zitzelsberger H, Jendrossek V, Klein D. Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells. Int J Mol Sci 2021;22:7064. [PMID: 34209135 DOI: 10.3390/ijms22137064] [Reference Citation Analysis]
26 Darling NJ, Cohen P. Nuts and bolts of the salt-inducible kinases (SIKs). Biochem J 2021;478:1377-97. [PMID: 33861845 DOI: 10.1042/BCJ20200502] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Tulipano G. Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area. Int J Mol Sci 2021;22:13068. [PMID: 34884872 DOI: 10.3390/ijms222313068] [Reference Citation Analysis]
28 León-González AJ, Jiménez-Vacas JM, Fuentes-Fayos AC, Sarmento-Cabral A, Herrera-Martínez AD, Gahete MD, Luque RM. Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers. Curr Opin Pharmacol 2021;60:17-26. [PMID: 34311387 DOI: 10.1016/j.coph.2021.06.002] [Reference Citation Analysis]
29 Jensterle M, Kravos NA, Dolžan V, Goričar K, Herman R, Rizzo M, Janež A. Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect? Endocrine 2021. [PMID: 34761355 DOI: 10.1007/s12020-021-02934-4] [Reference Citation Analysis]